HKEX: 3933 - The United Laboratories International Holdings Limited

Yield per half year: +49.27%
Sector: Healthcare

Company Analysis The United Laboratories International Holdings Limited

Download the report: word Word pdf PDF

1. Summary

Advantages

  • Price (8.71 HK$) is less than fair price (13.43 HK$)
  • Dividends (7.26%) are higher than the sector average (5.54%).
  • The stock's return over the last year (83.58%) is higher than the sector average (-28.88%).
  • Current debt level 11.7% is below 100% and has decreased over 5 years from 31.82%.
  • The company's current efficiency (ROE=23.14%) is higher than the sector average (ROE=5.19%)

Similar companies

Hangzhou Tigermed Consulting Co., Ltd

WuXi AppTec Co., Ltd.

CSPC Pharmaceutical Group Limited

Asymchem Laboratories (Tianjin) Co., Ltd.

2. Share price and performance

2.1. Share price

2.2. News

No news yet

2.3. Market efficiency

The United Laboratories International Holdings Limited Healthcare Index
7 days 7.3% -3.5% -1.6%
90 days 38.4% -13.4% -14.5%
1 year 83.6% -28.9% 18.7%

3933 vs Sector: The United Laboratories International Holdings Limited has outperformed the "Healthcare" sector by 112.46% over the past year.

3933 vs Market: The United Laboratories International Holdings Limited has outperformed the market by 64.88% over the past year.

Stable price: 3933 is not significantly more volatile than the rest of the market on "Hong Kong Exchanges" over the last 3 months, with typical variations of +/- 5% per week.

Long period: 3933 with weekly volatility of 1.61% over the past year.

3. Summary of the report

3.1. General

P/E: 4.04
P/S: 0.7937

3.2. Revenue

EPS 1.49
ROE 23.14%
ROA 13.51%
ROIC 0%
Ebitda margin 23.3%

4. Fundamental Analysis

4.1. Stock price and price forecast

The fair price is calculated taking into account the Central Bank refinancing rate and earnings per share (EPS)

Below fair price: The current price (8.71 HK$) is lower than the fair price (13.43 HK$).

Price significantly below the fair price: The current price (8.71 HK$) is 54.2% lower than the fair price.

4.2. P/E

P/E vs Sector: The company's P/E (4.04) is lower than that of the sector as a whole (35.42).

P/E vs Market: The company's P/E (4.04) is lower than that of the market as a whole (26.67).

4.2.1 P/E Similar companies

4.3. P/BV

P/BV vs Sector: The company's P/BV (0.8555) is lower than that of the sector as a whole (3.68).

P/BV vs Market: The company's P/BV (0.8555) is higher than that of the market as a whole (-11.94).

4.3.1 P/BV Similar companies

4.4. P/S

P/S vs Sector: The company's P/S indicator (0.7937) is lower than that of the sector as a whole (7.59).

P/S vs Market: The company's P/S indicator (0.7937) is lower than that of the market as a whole (2.77).

4.4.1 P/S Similar companies

4.5. EV/Ebitda

EV/Ebitda vs Sector: The company's EV/Ebitda (3.19) is higher than that of the sector as a whole (2.91).

EV/Ebitda vs Market: The company's EV/Ebitda (3.19) is lower than that of the market as a whole (9.94).

5. Profitability

5.1. Profitability and revenue

5.2. Earnings per share - EPS

5.3. Past profitability Net Income

Yield Trend: Rising and has grown by 56.85% over the last 5 years.

Earnings Slowdown: The last year's return (0%) is below the 5-year average return (56.85%).

Profitability vs Sector: The return for the last year (0%) is lower than the return for the sector (50.73%).

5.4. ROE

ROE vs Sector: The company's ROE (23.14%) is higher than that of the sector as a whole (5.19%).

ROE vs Market: The company's ROE (23.14%) is higher than that of the market as a whole (6.3%).

5.5. ROA

ROA vs Sector: The company's ROA (13.51%) is higher than that of the sector as a whole (3.47%).

ROA vs Market: The company's ROA (13.51%) is higher than that of the market as a whole (3.39%).

5.6. ROIC

ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (0%).

ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (0%).

6. Finance

6.1. Assets and debt

Debt level: (11.7%) is quite low in relation to assets.

Debt reduction: over 5 years, the debt has decreased from 31.82% to 11.7%.

Debt Covering: The debt is covered by 91.07% from net profit.

6.2. Profit growth and share price

7. Dividends

7.1. Dividend yield vs Market

High yield: The dividend yield of the company 7.26% is higher than the average for the sector '5.54%.

7.2. Stability and increase in payments

Dividend stability: The company's dividend yield 7.26% has been steadily paid over the past 7 years, DSI=1.

Dividend growth: Company's dividend yield 7.26% has been growing over the last 5 years. Growth over 5 years.

7.3. Payout percentage

Dividend Coverage: Current payments from income (21.52%) are at an uncomfortable level.

8. Insider trades

8.1. Insider trading

Insider Buying Exceeds insider sales by 100% over the last 3 months.

8.2. Latest transactions

No insider transactions have been recorded yet

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

9. Stocks forum The United Laboratories International Holdings Limited

9.3. Comments